You can access the videos of the IPF 2020 on the “Session Videos” page for 1 year with your login information.

Scientific Program

Istanbul Time Zone, UTC+3
12 December 2020 Saturday
09:00-09:26 Opening Ceremony
09:00-09:05 Welcome Speech Dr. John Davis
09:05-09:10 Welcome Speech Dr. M. Derya Balbay
09:10-09:13 Opening speech: History of IPF Dr. Atif Akdas
09:13-09:26 Opening speech: History of IPF Dr. Hiroki Watanabe
09:26-12:40 Session 1
Chairs: Dr. Satoru Takahashi, Dr. Erdem Canda
09:26-09:42 Is there a better symptom score than AUA-SI Dr. Ziya Kirkali
09:42-09:55 Medical management of benign prostatic hyperplasia (BPH) Dr. Melih Balci
09:55-10:11 Transperineal and transrectal prostate biopsy: Efficacy and Complications Dr. Badar  Mian 
10:11-10:22 Analysis of the big data of serum PSA value by age in medical examination for population over 260,000 Japanese men  Dr. Mineyuki  Kato
10:22-10:35 A novel dividing device of biopsy-tissue to enable both histopathological- and molecular-analysis of spatially matched tissues Dr. Takumi Shiraishi
10:35-10:50 Break
10:50-11:09 State of the Art Prostate MRI: What have we proven and where can we go further? Dr. Samir Taneja
11:09-11:26 Imaging Cases Dr. Samir Taneja
11:26-11:38 MRI tumor contact area: a novel clinical predictor for microscopic extra-prostate extension Dr. Yuta Inoue
11:38-11:56 Impact of pre-radical prostatectomy PSMA on decision-making Dr. Tarık Esen
11:56-12:13 PET Imaging: new agents coming?  Dr. Phillip Koo
12:13-12:40 Session 1-Questions and Answers (*)  
12:40-13:40 Satellite Symposium:
How Can Eligard 6 Months and Xtandi Contribute to Prostate Cancer Management During COVID-19 Pandemic?

Chairs: Dr. M. Derya Balbay, Dr. Mahmut Gumus
Speakers: Dr. Asif Yildirim, Dr. Ozcan Yildiz
13:40-17:42 Session 2
Chairs: Dr. Osamu Ukimura, Dr. Yilmaz Aslan
13:40-13:54 Active Surveillance Protocols for Everyday Practice Dr. Scott Eggener
13:54-14:16 Surgical cases for prostate cancer in ultimately high risk situation Dr. Shin Egawa
14:16-14:30 Robotic SP surgery at Yonsei Dr. Koonho Rha
14:30-14:50 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Christopher Eden
14:50-15:05 Break
15:05-15:12 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Aldo  Massimo Bocciardi 
15:12-15:29 Oligometastatic Prostate Cancer—Clinical Trial Updates and What to do in Clinical Practice Now Dr. Brian Francis Chapin 
15:29-15:40 Adjuvant versus salvage radiotherapy after radical prostatectomy Dr. Derya Tilki
15:40-15:53 Recent Discoveries in the Androgen Receptor Pathway in Prostate cancer Dr. Daisuke Obinata
15:53-16:10 Break
16:10-16:30 Testosterone Replacement for men with prostate cancer Dr. Abraham Morgentaler
16:30-16:43 Paradigm shift in radiotherapy: hypofractionation  Dr. Yasemin Bolukbasi
16:43-16:54 Is systemic treatment standart in localized high risk prostate cancer? Dr. Fuat Demirelli
16:54-17:12 Future directions in metastatic prostate cancer Dr. Ozcan Yildiz
17:12-17:42 Session 2-Questions and Answers (*)
13 December 2020 Sunday
09:30-11:30 Session 3-New Technologies in BPH Surgical Treatment
Chair: Dr. Altug Tuncel
09:30-09:45 Bipolar enucleation of the prostate (BipoLEP) Dr. Altug Tuncel
09:45-10:05 Greenlight laser prostatectomy and benefits for anticoagulated men in large prostates Dr. Kevin C. Zorn
10:05-10:20 Procedural Essentials on HoLEP Dr. Peter Schatteman
10:20-10:35 Holmium laser enucleation of the prostate (HoLEP): presenting 10 most important tips in 10 minutes, single surgeon Turkish experience with >500 cases Dr. Murat Arslan
10:35-10:49 Thulium laser enucleation of the prostate (ThuLEP) during the New Technologies Dr. Thomas Herrmann
10:49-11:04 Thulium laser vaporesection of the prostate Dr. Hashim Hashim
11:04-11:30 Session 3-Questions and Answers  
11:30-11:45 Break
11:45-13:30 Session 4-Best of 10th EUA 2020
Chair:  Dr. Murat Can Kiremit
11:45-12:05 Oligometastatic Prostate Cancer – The perspective from Radiation Oncologist Dr. Hale Caglar
12:05-12:47 World Urologic Oncology Federation (WUOF) Lecture: Novel tools in the Active Surveillance pathway Dr. Laurence Klotz
12:47-13:10 Integrative Oncology in Prostate Cancer Dr. Omer Kucuk
13:10-13:30 Molecular classification and clinical reflections in prostate cancer Dr. Oner Sanli
13:30-13:50 Molecular decision making in prostate cancer: unlocking the mystery of localised disease Dr. Alastair D Lamb
13:50-14:30 Lunch Break
14:30-17:00 Session 5-Abstract Presentations
Chairs: Dr. Asif Yildirim, Dr. Erdem Canda
Pub Number Title Presenter
S-01 A Patient With Solitary Femoral Head Metastasis From Prostate Cancer Treated With Multidisiplinary Approach Ali Yasin Ozercan
S-02 The significance of prostate weight on complications in robotic radical prostatectomy Erdem Koc
S-03 Outcomes of robotic radical prostatectomy in patients with prostates ≥120 grams Ersin Koseoglu
S-04 Outcomes of robotic radical prostatectomy in patients <50 years old Ersin Koseoglu
S-05 Correlation of prostate biopsy and surgery pathologies in prostate cancer: ISUP grade, tumor volume and laterality variance Huseyin Cihan Demirel
S-06 Vesical and urethral Hem-O-Lock clip migrations after robot assisted laparoscopic radical prostatectomy: Our clinical experiences Mahmut Taha Olcucu
S-07 Assessment of CRP to determine antibiotic use in patients with elevated PSA values Mahmut Taha Olcucu
S-08 Our experiences with robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-09 The İmportance of Pretreatment PNI in Predicting PSA Recurrence After Radical Prostatectomy Mecit Celik
S-10 Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications Mehmet Sefa Altay
S-11 Reliability of robot-assisted radical prostatectomy applied during the Covid 19 (Sars-CoV-2) pandemic: Experiences of a pandemic hospital Mehmet Sefa Altay
S-12 Risk Factors of the Pathological Upgrading after Radical Prostatectomy in Low-Risk and İntermediate-Risk Prostate Cancer Patients Who are in Group ISUP-1 Murat Sahan
S-13 Failed antegrade flexible ureteroscopy experience in a patient with distal ureteral stricture, who has undergone ureteroneocystostomy during radical prostatectomy and successful psoas hitch and reimplantation procedure Oguz Ozcan
S-14 Fate of the unnoticed prostate carcinoma Ozer Ural Cakici
S-15 Comparison of targeted biopsies using magnetic resonance imaging/ultrasonography fusion with conventional transrectal ultrasonography-guided biopsies for clinically significant prostate cancer Salih Polat
S-16 Can the time of biochemical recurrence after radical prostatectomy be predicted with the CAPRA-S score? Samet Senel
S-17 The diagnostic accuracy of Ga68 PSMA PET/CT on clinical lymph node staging before radical prostatectomy in intermediate or high risk prostate cancer: The results of patient and lymph node based analyses Selcuk Erdem
S-18 Predictive Factors Of Biochemical Recurrence In pN+ Prostate Cancer Semih Aktas
S-19 Large Cell Neuroendocrine Carcinoma Of The Prostate: A Rare Case Serkan Ozcan
S-20 Transperitoneal laparoscopic radical prostatectomy: Single center exprience Sevket Tolga Tombul
S-21 MRI targeted fusion prostate biopsy as a second biopsy after previous negative MRI targeted biopsy. Sevket Tolga Tombul
S-22 Evaluation of the persistent PSA via PSMA-PET/CT after radical prostatectomy: our experience with 12 patients Uygar Micoogullari
S-23 Comparison of Gleason upgrading rates in US-MRI fusion biopsy versus transrectal ultrasound systematic biopsy for prostate cancer Yavuz Onur Danacioglu
S-24 Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate: A short term follow-up Ibrahim Can Aykanat
S-25 Comparison of Effects of Tamsulosin and Silodosin on Subfoveal Choroidal Thickness and Pupil Size Diameters in Patients with Prostatic Hyperplasia Mahmut Taha Olcucu
S-26 A Randomized-Controlled, Prospective Study on the Effect of Dorsal Penile Nerve Block after TURP on Catheter-Related Bladder Discomfort and Pain Mehmet Serkan Ozkent
S-27 Lateral aprroach Retzius-sparing robot-assisted laparoscopic prostatectomy: The results of the first 15 cases of our new modified technique Mahmut Taha Olcucu
S-28 Ergonomic evaluation of radical prostatectomy techniques Mahmut Taha Olcucu
S-29 Evaluation of peritoneal re-aprroximation types on symptomatic lymphocele formation after robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-30 Has the Pandemic Affected Follow-Up of BPH and Prostate Cancer Patients? Abdullah Cirakoglu
S-31 Investigation of the Effect of Bowel Cleansing on Infection and Pathology Results Before Transrectal Ultrasonography-Guided Prostate Biopsy Adem Tuncekin
S-32 Investigation of the Relationship Between Prophylactic Antibiotic Type and Infection in Transrectal Ultrasound Guided Prostate Biopsy Adem Tuncekin
S-33 Can LUC (Large Unstained Cell) values play a predictive role in preventing unnecessary biopsy due to prostatitis? Bugra Bilge Keseroglu
S-34 Hounsfield Units (HU): Promissing Non-Invasive Tool for Diagnosing Benign Prostatic Hyperplasia (BPH) Cumhur Yesildal
S-35 Granulomatous Prostatitis Due To Intravesical BCG Treatment Huseyin Cihan Demirel
S-36 A Rare Prostate Pathology: Mantle Cell Lymphoma Selman Unal
V-01 Preservation of Accesory Pudental Arteries in Robot-Assited Radical Prostatectomy Yusuf Arikan
17:00-17:10 Closing remarks Dr. Erdem Canda
New York Time Zone, UTC-5
12 December 2020 Saturday
01:00-01:26 Opening Ceremony
01:00-01:05 Welcome Speech Dr. John Davis
01:05-01:10 Welcome Speech Dr. M. Derya Balbay
01:10-01:13 Opening speech: History of IPF Dr. Atif Akdas
01:13-01:26 Opening speech: History of IPF Dr. Hiroki Watanabe
01:26-04:40 Session 1
Chairs: Dr. Satoru Takahashi, Dr. Erdem Canda
01:26-01:42 Is there a better symptom score than AUA-SI Dr. Ziya Kirkali
01:42-01:55 Medical management of benign prostatic hyperplasia (BPH) Dr. Melih Balci
01:55-02:11 Transperineal and transrectal prostate biopsy: Efficacy and Complications Dr. Badar  Mian 
02:11-02:22 Analysis of the big data of serum PSA value by age in medical examination for population over 260,000 Japanese men  Dr. Mineyuki  Kato
02:22-02:35 A novel dividing device of biopsy-tissue to enable both histopathological- and molecular-analysis of spatially matched tissues Dr. Takumi Shiraishi
02:35-02:50 Break
02:50-03:09 State of the Art Prostate MRI: What have we proven and where can we go further? Dr. Samir Taneja
03:09-03:26 Imaging Cases Dr. Samir Taneja
03:26-03:38 MRI tumor contact area: a novel clinical predictor for microscopic extra-prostate extension Dr. Yuta Inoue
03:38-03:56 Impact of pre-radical prostatectomy PSMA on decision-making Dr. Tarık Esen
03:56-04:13 PET Imaging: new agents coming?  Dr. Phillip Koo
04:13-04:40 Session 1-Questions and Answers (*)  
04:40-05:40 Satellite Symposium:
How Can Eligard 6 Months and Xtandi Contribute to Prostate Cancer Management During COVID-19 Pandemic?

Chairs: Dr. M. Derya Balbay, Dr. Mahmut Gumus
Speakers: Dr. Asif Yildirim, Dr. Ozcan Yildiz
05:40-09:42 Session 2
Chairs: Dr. Osamu Ukimura, Dr. Yilmaz Aslan
05:40-05:54 Active Surveillance Protocols for Everyday Practice Dr. Scott Eggener
05:54-06:16 Surgical cases for prostate cancer in ultimately high risk situation Dr. Shin Egawa
06:16-06:30 Robotic SP surgery at Yonsei Dr. Koonho Rha
06:30-06:50 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Christopher Eden
06:50-07:05 Break
07:05-07:12 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Aldo  Massimo Bocciardi 
07:12-07:29 Oligometastatic Prostate Cancer—Clinical Trial Updates and What to do in Clinical Practice Now Dr. Brian Francis Chapin 
07:29-07:40 Adjuvant versus salvage radiotherapy after radical prostatectomy Dr. Derya Tilki
07:40-07:53 Recent Discoveries in the Androgen Receptor Pathway in Prostate cancer Dr. Daisuke Obinata
07:53-08:10 Break
08:10-08:30 Testosterone Replacement for men with prostate cancer Dr. Abraham Morgentaler
08:30-08:43 Paradigm shift in radiotherapy: hypofractionation  Dr. Yasemin Bolukbasi
08:43-08:54 Is systemic treatment standart in localized high risk prostate cancer? Dr. Fuat Demirelli
08:54-09:12 Future directions in metastatic prostate cancer Dr. Ozcan Yildiz
09:12-09:42 Session 2-Questions and Answers (*)
13 December 2020 Sunday
01:30-03:30 Session 3-New Technologies in BPH Surgical Treatment
Chair: Dr. Altug Tuncel
01:30-01:45 Bipolar enucleation of the prostate (BipoLEP) Dr. Altug Tuncel
01:45-02:05 Greenlight laser prostatectomy and benefits for anticoagulated men in large prostates Dr. Kevin C. Zorn
02:05-02:20 Procedural Essentials on HoLEP Dr. Peter Schatteman
02:20-02:35 Holmium laser enucleation of the prostate (HoLEP): presenting 10 most important tips in 10 minutes, single surgeon Turkish experience with >500 cases Dr. Murat Arslan
02:35-02:49 Thulium laser enucleation of the prostate (ThuLEP) during the New Technologies Dr. Thomas Herrmann
02:49-03:04 Thulium laser vaporesection of the prostate Dr. Hashim Hashim
03:04-03:30 Session 3-Questions and Answers  
03:30-03:45 Break
03:45-05:30 Session 4-Best of 10th EUA 2020
Chair:  Dr. Murat Can Kiremit
03:45-04:05 Oligometastatic Prostate Cancer – The perspective from Radiation Oncologist Dr. Hale Caglar
04:05-04:47 World Urologic Oncology Federation (WUOF) Lecture: Novel tools in the Active Surveillance pathway Dr. Laurence Klotz
04:47-05:10 Integrative Oncology in Prostate Cancer Dr. Omer Kucuk
05:10-05:30 Molecular classification and clinical reflections in prostate cancer Dr. Oner Sanli
05:30-05:50 Molecular decision making in prostate cancer: unlocking the mystery of localised disease Dr. Alastair D Lamb
05:50-06:30 Lunch Break
06:30-09:00 Session 5-Abstract Presentations
Chairs: Dr. Asif Yildirim, Dr. Erdem Canda
Pub Number Title Presenter
S-01 A Patient With Solitary Femoral Head Metastasis From Prostate Cancer Treated With Multidisiplinary Approach Ali Yasin Ozercan
S-02 The significance of prostate weight on complications in robotic radical prostatectomy Erdem Koc
S-03 Outcomes of robotic radical prostatectomy in patients with prostates ≥120 grams Ersin Koseoglu
S-04 Outcomes of robotic radical prostatectomy in patients <50 years old Ersin Koseoglu
S-05 Correlation of prostate biopsy and surgery pathologies in prostate cancer: ISUP grade, tumor volume and laterality variance Huseyin Cihan Demirel
S-06 Vesical and urethral Hem-O-Lock clip migrations after robot assisted laparoscopic radical prostatectomy: Our clinical experiences Mahmut Taha Olcucu
S-07 Assessment of CRP to determine antibiotic use in patients with elevated PSA values Mahmut Taha Olcucu
S-08 Our experiences with robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-09 The İmportance of Pretreatment PNI in Predicting PSA Recurrence After Radical Prostatectomy Mecit Celik
S-10 Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications Mehmet Sefa Altay
S-11 Reliability of robot-assisted radical prostatectomy applied during the Covid 19 (Sars-CoV-2) pandemic: Experiences of a pandemic hospital Mehmet Sefa Altay
S-12 Risk Factors of the Pathological Upgrading after Radical Prostatectomy in Low-Risk and İntermediate-Risk Prostate Cancer Patients Who are in Group ISUP-1 Murat Sahan
S-13 Failed antegrade flexible ureteroscopy experience in a patient with distal ureteral stricture, who has undergone ureteroneocystostomy during radical prostatectomy and successful psoas hitch and reimplantation procedure Oguz Ozcan
S-14 Fate of the unnoticed prostate carcinoma Ozer Ural Cakici
S-15 Comparison of targeted biopsies using magnetic resonance imaging/ultrasonography fusion with conventional transrectal ultrasonography-guided biopsies for clinically significant prostate cancer Salih Polat
S-16 Can the time of biochemical recurrence after radical prostatectomy be predicted with the CAPRA-S score? Samet Senel
S-17 The diagnostic accuracy of Ga68 PSMA PET/CT on clinical lymph node staging before radical prostatectomy in intermediate or high risk prostate cancer: The results of patient and lymph node based analyses Selcuk Erdem
S-18 Predictive Factors Of Biochemical Recurrence In pN+ Prostate Cancer Semih Aktas
S-19 Large Cell Neuroendocrine Carcinoma Of The Prostate: A Rare Case Serkan Ozcan
S-20 Transperitoneal laparoscopic radical prostatectomy: Single center exprience Sevket Tolga Tombul
S-21 MRI targeted fusion prostate biopsy as a second biopsy after previous negative MRI targeted biopsy. Sevket Tolga Tombul
S-22 Evaluation of the persistent PSA via PSMA-PET/CT after radical prostatectomy: our experience with 12 patients Uygar Micoogullari
S-23 Comparison of Gleason upgrading rates in US-MRI fusion biopsy versus transrectal ultrasound systematic biopsy for prostate cancer Yavuz Onur Danacioglu
S-24 Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate: A short term follow-up Ibrahim Can Aykanat
S-25 Comparison of Effects of Tamsulosin and Silodosin on Subfoveal Choroidal Thickness and Pupil Size Diameters in Patients with Prostatic Hyperplasia Mahmut Taha Olcucu
S-26 A Randomized-Controlled, Prospective Study on the Effect of Dorsal Penile Nerve Block after TURP on Catheter-Related Bladder Discomfort and Pain Mehmet Serkan Ozkent
S-27 Lateral aprroach Retzius-sparing robot-assisted laparoscopic prostatectomy: The results of the first 15 cases of our new modified technique Mahmut Taha Olcucu
S-28 Ergonomic evaluation of radical prostatectomy techniques Mahmut Taha Olcucu
S-29 Evaluation of peritoneal re-aprroximation types on symptomatic lymphocele formation after robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-30 Has the Pandemic Affected Follow-Up of BPH and Prostate Cancer Patients? Abdullah Cirakoglu
S-31 Investigation of the Effect of Bowel Cleansing on Infection and Pathology Results Before Transrectal Ultrasonography-Guided Prostate Biopsy Adem Tuncekin
S-32 Investigation of the Relationship Between Prophylactic Antibiotic Type and Infection in Transrectal Ultrasound Guided Prostate Biopsy Adem Tuncekin
S-33 Can LUC (Large Unstained Cell) values play a predictive role in preventing unnecessary biopsy due to prostatitis? Bugra Bilge Keseroglu
S-34 Hounsfield Units (HU): Promissing Non-Invasive Tool for Diagnosing Benign Prostatic Hyperplasia (BPH) Cumhur Yesildal
S-35 Granulomatous Prostatitis Due To Intravesical BCG Treatment Huseyin Cihan Demirel
S-36 A Rare Prostate Pathology: Mantle Cell Lymphoma Selman Unal
V-01 Preservation of Accesory Pudental Arteries in Robot-Assited Radical Prostatectomy Yusuf Arikan
09:00-09:10 Closing remarks Dr. Erdem Canda
Berlin Time Zone, UTC+1
12 December 2020 Saturday
07:00-07:26 Opening Ceremony
07:00-07:05 Welcome Speech Dr. John Davis
07:05-07:10 Welcome Speech Dr. M. Derya Balbay
07:10-07:13 Opening speech: History of IPF Dr. Atif Akdas
07:13-07:26 Opening speech: History of IPF Dr. Hiroki Watanabe
07:26-10:40 Session 1
Chairs: Dr. Satoru Takahashi, Dr. Erdem Canda
07:26-07:42 Is there a better symptom score than AUA-SI Dr. Ziya Kirkali
07:42-07:55 Medical management of benign prostatic hyperplasia (BPH) Dr. Melih Balci
07:55-08:11 Transperineal and transrectal prostate biopsy: Efficacy and Complications Dr. Badar  Mian 
08:11-08:22 Analysis of the big data of serum PSA value by age in medical examination for population over 260,000 Japanese men  Dr. Mineyuki  Kato
08:22-08:35 A novel dividing device of biopsy-tissue to enable both histopathological- and molecular-analysis of spatially matched tissues Dr. Takumi Shiraishi
08:35-08:50 Break
08:50-09:09 State of the Art Prostate MRI: What have we proven and where can we go further? Dr. Samir Taneja
09:09-09:26 Imaging Cases Dr. Samir Taneja
09:26-09:38 MRI tumor contact area: a novel clinical predictor for microscopic extra-prostate extension Dr. Yuta Inoue
09:38-09:56 Impact of pre-radical prostatectomy PSMA on decision-making Dr. Tarık Esen
09:56-10:13 PET Imaging: new agents coming?  Dr. Phillip Koo
10:13-10:40 Session 1-Questions and Answers (*)  
10:40-11:40 Satellite Symposium:
How Can Eligard 6 Months and Xtandi Contribute to Prostate Cancer Management During COVID-19 Pandemic?

Chairs: Dr. M. Derya Balbay, Dr. Mahmut Gumus
Speakers: Dr. Asif Yildirim, Dr. Ozcan Yildiz
11:40-15:42 Session 2
Chairs: Dr. Osamu Ukimura, Dr. Yilmaz Aslan
11:40-11:54 Active Surveillance Protocols for Everyday Practice Dr. Scott Eggener
11:54-12:16 Surgical cases for prostate cancer in ultimately high risk situation Dr. Shin Egawa
12:16-12:30 Robotic SP surgery at Yonsei Dr. Koonho Rha
12:30-12:50 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Christopher Eden
12:50-13:05 Break
13:05-13:12 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Aldo  Massimo Bocciardi 
13:12-13:29 Oligometastatic Prostate Cancer—Clinical Trial Updates and What to do in Clinical Practice Now Dr. Brian Francis Chapin 
13:29-13:40 Adjuvant versus salvage radiotherapy after radical prostatectomy Dr. Derya Tilki
13:40-13:53 Recent Discoveries in the Androgen Receptor Pathway in Prostate cancer Dr. Daisuke Obinata
13:53-14:10 Break
14:10-14:30 Testosterone Replacement for men with prostate cancer Dr. Abraham Morgentaler
14:30-14:43 Paradigm shift in radiotherapy: hypofractionation  Dr. Yasemin Bolukbasi
14:43-14:54 Is systemic treatment standart in localized high risk prostate cancer? Dr. Fuat Demirelli
14:54-15:12 Future directions in metastatic prostate cancer Dr. Ozcan Yildiz
15:12-15:42 Session 2-Questions and Answers (*)
13 December 2020 Sunday
07:30-09:30 Session 3-New Technologies in BPH Surgical Treatment
Chair: Dr. Altug Tuncel
07:30-07:45 Bipolar enucleation of the prostate (BipoLEP) Dr. Altug Tuncel
07:45-08:05 Greenlight laser prostatectomy and benefits for anticoagulated men in large prostates Dr. Kevin C. Zorn
08:05-08:20 Procedural Essentials on HoLEP Dr. Peter Schatteman
08:20-08:35 Holmium laser enucleation of the prostate (HoLEP): presenting 10 most important tips in 10 minutes, single surgeon Turkish experience with >500 cases Dr. Murat Arslan
08:35-08:49 Thulium laser enucleation of the prostate (ThuLEP) during the New Technologies Dr. Thomas Herrmann
08:49-09:04 Thulium laser vaporesection of the prostate Dr. Hashim Hashim
09:04-09:30 Session 3-Questions and Answers  
09:30-09:45 Break
09:45-11:30 Session 4-Best of 10th EUA 2020
Chair:  Dr. Murat Can Kiremit
09:45-10:05 Oligometastatic Prostate Cancer – The perspective from Radiation Oncologist Dr. Hale Caglar
10:05-10:47 World Urologic Oncology Federation (WUOF) Lecture: Novel tools in the Active Surveillance pathway Dr. Laurence Klotz
10:47-11:10 Integrative Oncology in Prostate Cancer Dr. Omer Kucuk
11:10-11:30 Molecular classification and clinical reflections in prostate cancer Dr. Oner Sanli
11:30-11:50 Molecular decision making in prostate cancer: unlocking the mystery of localised disease Dr. Alastair D Lamb
11:50-12:30 Lunch Break
12:30-15:00 Session 5-Abstract Presentations
Chairs: Dr. Asif Yildirim, Dr. Erdem Canda
Pub Number Title Presenter
S-01 A Patient With Solitary Femoral Head Metastasis From Prostate Cancer Treated With Multidisiplinary Approach Ali Yasin Ozercan
S-02 The significance of prostate weight on complications in robotic radical prostatectomy Erdem Koc
S-03 Outcomes of robotic radical prostatectomy in patients with prostates ≥120 grams Ersin Koseoglu
S-04 Outcomes of robotic radical prostatectomy in patients <50 years old Ersin Koseoglu
S-05 Correlation of prostate biopsy and surgery pathologies in prostate cancer: ISUP grade, tumor volume and laterality variance Huseyin Cihan Demirel
S-06 Vesical and urethral Hem-O-Lock clip migrations after robot assisted laparoscopic radical prostatectomy: Our clinical experiences Mahmut Taha Olcucu
S-07 Assessment of CRP to determine antibiotic use in patients with elevated PSA values Mahmut Taha Olcucu
S-08 Our experiences with robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-09 The İmportance of Pretreatment PNI in Predicting PSA Recurrence After Radical Prostatectomy Mecit Celik
S-10 Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications Mehmet Sefa Altay
S-11 Reliability of robot-assisted radical prostatectomy applied during the Covid 19 (Sars-CoV-2) pandemic: Experiences of a pandemic hospital Mehmet Sefa Altay
S-12 Risk Factors of the Pathological Upgrading after Radical Prostatectomy in Low-Risk and İntermediate-Risk Prostate Cancer Patients Who are in Group ISUP-1 Murat Sahan
S-13 Failed antegrade flexible ureteroscopy experience in a patient with distal ureteral stricture, who has undergone ureteroneocystostomy during radical prostatectomy and successful psoas hitch and reimplantation procedure Oguz Ozcan
S-14 Fate of the unnoticed prostate carcinoma Ozer Ural Cakici
S-15 Comparison of targeted biopsies using magnetic resonance imaging/ultrasonography fusion with conventional transrectal ultrasonography-guided biopsies for clinically significant prostate cancer Salih Polat
S-16 Can the time of biochemical recurrence after radical prostatectomy be predicted with the CAPRA-S score? Samet Senel
S-17 The diagnostic accuracy of Ga68 PSMA PET/CT on clinical lymph node staging before radical prostatectomy in intermediate or high risk prostate cancer: The results of patient and lymph node based analyses Selcuk Erdem
S-18 Predictive Factors Of Biochemical Recurrence In pN+ Prostate Cancer Semih Aktas
S-19 Large Cell Neuroendocrine Carcinoma Of The Prostate: A Rare Case Serkan Ozcan
S-20 Transperitoneal laparoscopic radical prostatectomy: Single center exprience Sevket Tolga Tombul
S-21 MRI targeted fusion prostate biopsy as a second biopsy after previous negative MRI targeted biopsy. Sevket Tolga Tombul
S-22 Evaluation of the persistent PSA via PSMA-PET/CT after radical prostatectomy: our experience with 12 patients Uygar Micoogullari
S-23 Comparison of Gleason upgrading rates in US-MRI fusion biopsy versus transrectal ultrasound systematic biopsy for prostate cancer Yavuz Onur Danacioglu
S-24 Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate: A short term follow-up Ibrahim Can Aykanat
S-25 Comparison of Effects of Tamsulosin and Silodosin on Subfoveal Choroidal Thickness and Pupil Size Diameters in Patients with Prostatic Hyperplasia Mahmut Taha Olcucu
S-26 A Randomized-Controlled, Prospective Study on the Effect of Dorsal Penile Nerve Block after TURP on Catheter-Related Bladder Discomfort and Pain Mehmet Serkan Ozkent
S-27 Lateral aprroach Retzius-sparing robot-assisted laparoscopic prostatectomy: The results of the first 15 cases of our new modified technique Mahmut Taha Olcucu
S-28 Ergonomic evaluation of radical prostatectomy techniques Mahmut Taha Olcucu
S-29 Evaluation of peritoneal re-aprroximation types on symptomatic lymphocele formation after robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-30 Has the Pandemic Affected Follow-Up of BPH and Prostate Cancer Patients? Abdullah Cirakoglu
S-31 Investigation of the Effect of Bowel Cleansing on Infection and Pathology Results Before Transrectal Ultrasonography-Guided Prostate Biopsy Adem Tuncekin
S-32 Investigation of the Relationship Between Prophylactic Antibiotic Type and Infection in Transrectal Ultrasound Guided Prostate Biopsy Adem Tuncekin
S-33 Can LUC (Large Unstained Cell) values play a predictive role in preventing unnecessary biopsy due to prostatitis? Bugra Bilge Keseroglu
S-34 Hounsfield Units (HU): Promissing Non-Invasive Tool for Diagnosing Benign Prostatic Hyperplasia (BPH) Cumhur Yesildal
S-35 Granulomatous Prostatitis Due To Intravesical BCG Treatment Huseyin Cihan Demirel
S-36 A Rare Prostate Pathology: Mantle Cell Lymphoma Selman Unal
V-01 Preservation of Accesory Pudental Arteries in Robot-Assited Radical Prostatectomy Yusuf Arikan
15:00-15:10 Closing remarks Dr. Erdem Canda
Tokyo Time Zone, UTC+9
12 December 2020 Saturday
15:00-15:26 Opening Ceremony
15:00-15:05 Welcome Speech Dr. John Davis
15:05-15:10 Welcome Speech Dr. M. Derya Balbay
15:10-15:13 Opening speech: History of IPF Dr. Atif Akdas
15:13-15:26 Opening speech: History of IPF Dr. Hiroki Watanabe
15:26-18:40 Session 1
Chairs: Dr. Satoru Takahashi, Dr. Erdem Canda
15:26-15:42 Is there a better symptom score than AUA-SI Dr. Ziya Kirkali
15:42-15:55 Medical management of benign prostatic hyperplasia (BPH) Dr. Melih Balci
15:55-16:11 Transperineal and transrectal prostate biopsy: Efficacy and Complications Dr. Badar  Mian 
16:11-16:22 Analysis of the big data of serum PSA value by age in medical examination for population over 260,000 Japanese men  Dr. Mineyuki  Kato
16:22-16:35 A novel dividing device of biopsy-tissue to enable both histopathological- and molecular-analysis of spatially matched tissues Dr. Takumi Shiraishi
16:35-16:50 Break
16:50-17:09 State of the Art Prostate MRI: What have we proven and where can we go further? Dr. Samir Taneja
17:09-17:26 Imaging Cases Dr. Samir Taneja
17:26-17:38 MRI tumor contact area: a novel clinical predictor for microscopic extra-prostate extension Dr. Yuta Inoue
17:38-17:56 Impact of pre-radical prostatectomy PSMA on decision-making Dr. Tarık Esen
17:56-18:13 PET Imaging: new agents coming?  Dr. Phillip Koo
18:13-18:40 Session 1-Questions and Answers (*)  
18:40-19:40 Satellite Symposium:
How Can Eligard 6 Months and Xtandi Contribute to Prostate Cancer Management During COVID-19 Pandemic?

Chairs: Dr. M. Derya Balbay, Dr. Mahmut Gumus
Speakers: Dr. Asif Yildirim, Dr. Ozcan Yildiz
19:40-23:42 Session 2
Chairs: Dr. Osamu Ukimura, Dr. Yilmaz Aslan
19:40-19:54 Active Surveillance Protocols for Everyday Practice Dr. Scott Eggener
19:54-20:16 Surgical cases for prostate cancer in ultimately high risk situation Dr. Shin Egawa
20:16-20:30 Robotic SP surgery at Yonsei Dr. Koonho Rha
20:30-20:50 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Christopher Eden
20:50-21:05 Break
21:05-21:12 Retzius-sparing robotic radical prostatectomy: How I do it? Dr. Aldo  Massimo Bocciardi 
21:12-21:29 Oligometastatic Prostate Cancer—Clinical Trial Updates and What to do in Clinical Practice Now Dr. Brian Francis Chapin 
21:29-21:40 Adjuvant versus salvage radiotherapy after radical prostatectomy Dr. Derya Tilki
21:40-21:53 Recent Discoveries in the Androgen Receptor Pathway in Prostate cancer Dr. Daisuke Obinata
21:53-22:10 Break
22:10-22:30 Testosterone Replacement for men with prostate cancer Dr. Abraham Morgentaler
22:30-22:43 Paradigm shift in radiotherapy: hypofractionation  Dr. Yasemin Bolukbasi
22:43-22:54 Is systemic treatment standart in localized high risk prostate cancer? Dr. Fuat Demirelli
22:54-23:12 Future directions in metastatic prostate cancer Dr. Ozcan Yildiz
23:12-23:42 Session 2-Questions and Answers (*)
13 December 2020 Sunday
15:30-17:30 Session 3-New Technologies in BPH Surgical Treatment
Chair: Dr. Altug Tuncel
15:30-15:45 Bipolar enucleation of the prostate (BipoLEP) Dr. Altug Tuncel
15:45-16:05 Greenlight laser prostatectomy and benefits for anticoagulated men in large prostates Dr. Kevin C. Zorn
16:05-16:20 Procedural Essentials on HoLEP Dr. Peter Schatteman
16:20-16:35 Holmium laser enucleation of the prostate (HoLEP): presenting 10 most important tips in 10 minutes, single surgeon Turkish experience with >500 cases Dr. Murat Arslan
16:35-16:49 Thulium laser enucleation of the prostate (ThuLEP) during the New Technologies Dr. Thomas Herrmann
16:49-17:04 Thulium laser vaporesection of the prostate Dr. Hashim Hashim
17:04-17:30 Session 3-Questions and Answers  
17:30-17:45 Break
17:45-19:30 Session 4-Best of 10th EUA 2020
Chair:  Dr. Murat Can Kiremit
17:45-18:05 Oligometastatic Prostate Cancer – The perspective from Radiation Oncologist Dr. Hale Caglar
18:05-18:47 World Urologic Oncology Federation (WUOF) Lecture: Novel tools in the Active Surveillance pathway Dr. Laurence Klotz
18:47-19:10 Integrative Oncology in Prostate Cancer Dr. Omer Kucuk
19:10-19:30 Molecular classification and clinical reflections in prostate cancer Dr. Oner Sanli
19:30-19:50 Molecular decision making in prostate cancer: unlocking the mystery of localised disease Dr. Alastair D Lamb
19:50-20:30 Lunch Break
20:30-23:00 Session 5-Abstract Presentations
Chairs: Dr. Asif Yildirim, Dr. Erdem Canda
Pub Number Title Presenter
S-01 A Patient With Solitary Femoral Head Metastasis From Prostate Cancer Treated With Multidisiplinary Approach Ali Yasin Ozercan
S-02 The significance of prostate weight on complications in robotic radical prostatectomy Erdem Koc
S-03 Outcomes of robotic radical prostatectomy in patients with prostates ≥120 grams Ersin Koseoglu
S-04 Outcomes of robotic radical prostatectomy in patients <50 years old Ersin Koseoglu
S-05 Correlation of prostate biopsy and surgery pathologies in prostate cancer: ISUP grade, tumor volume and laterality variance Huseyin Cihan Demirel
S-06 Vesical and urethral Hem-O-Lock clip migrations after robot assisted laparoscopic radical prostatectomy: Our clinical experiences Mahmut Taha Olcucu
S-07 Assessment of CRP to determine antibiotic use in patients with elevated PSA values Mahmut Taha Olcucu
S-08 Our experiences with robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-09 The İmportance of Pretreatment PNI in Predicting PSA Recurrence After Radical Prostatectomy Mecit Celik
S-10 Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications Mehmet Sefa Altay
S-11 Reliability of robot-assisted radical prostatectomy applied during the Covid 19 (Sars-CoV-2) pandemic: Experiences of a pandemic hospital Mehmet Sefa Altay
S-12 Risk Factors of the Pathological Upgrading after Radical Prostatectomy in Low-Risk and İntermediate-Risk Prostate Cancer Patients Who are in Group ISUP-1 Murat Sahan
S-13 Failed antegrade flexible ureteroscopy experience in a patient with distal ureteral stricture, who has undergone ureteroneocystostomy during radical prostatectomy and successful psoas hitch and reimplantation procedure Oguz Ozcan
S-14 Fate of the unnoticed prostate carcinoma Ozer Ural Cakici
S-15 Comparison of targeted biopsies using magnetic resonance imaging/ultrasonography fusion with conventional transrectal ultrasonography-guided biopsies for clinically significant prostate cancer Salih Polat
S-16 Can the time of biochemical recurrence after radical prostatectomy be predicted with the CAPRA-S score? Samet Senel
S-17 The diagnostic accuracy of Ga68 PSMA PET/CT on clinical lymph node staging before radical prostatectomy in intermediate or high risk prostate cancer: The results of patient and lymph node based analyses Selcuk Erdem
S-18 Predictive Factors Of Biochemical Recurrence In pN+ Prostate Cancer Semih Aktas
S-19 Large Cell Neuroendocrine Carcinoma Of The Prostate: A Rare Case Serkan Ozcan
S-20 Transperitoneal laparoscopic radical prostatectomy: Single center exprience Sevket Tolga Tombul
S-21 MRI targeted fusion prostate biopsy as a second biopsy after previous negative MRI targeted biopsy. Sevket Tolga Tombul
S-22 Evaluation of the persistent PSA via PSMA-PET/CT after radical prostatectomy: our experience with 12 patients Uygar Micoogullari
S-23 Comparison of Gleason upgrading rates in US-MRI fusion biopsy versus transrectal ultrasound systematic biopsy for prostate cancer Yavuz Onur Danacioglu
S-24 Clinical Comparison of Holmium Laser Enucleation of the Prostate and Bipolar Transurethral Enucleation of the Prostate: A short term follow-up Ibrahim Can Aykanat
S-25 Comparison of Effects of Tamsulosin and Silodosin on Subfoveal Choroidal Thickness and Pupil Size Diameters in Patients with Prostatic Hyperplasia Mahmut Taha Olcucu
S-26 A Randomized-Controlled, Prospective Study on the Effect of Dorsal Penile Nerve Block after TURP on Catheter-Related Bladder Discomfort and Pain Mehmet Serkan Ozkent
S-27 Lateral aprroach Retzius-sparing robot-assisted laparoscopic prostatectomy: The results of the first 15 cases of our new modified technique Mahmut Taha Olcucu
S-28 Ergonomic evaluation of radical prostatectomy techniques Mahmut Taha Olcucu
S-29 Evaluation of peritoneal re-aprroximation types on symptomatic lymphocele formation after robot-assisted laparoscopic radical prostatectomy Mahmut Taha Olcucu
S-30 Has the Pandemic Affected Follow-Up of BPH and Prostate Cancer Patients? Abdullah Cirakoglu
S-31 Investigation of the Effect of Bowel Cleansing on Infection and Pathology Results Before Transrectal Ultrasonography-Guided Prostate Biopsy Adem Tuncekin
S-32 Investigation of the Relationship Between Prophylactic Antibiotic Type and Infection in Transrectal Ultrasound Guided Prostate Biopsy Adem Tuncekin
S-33 Can LUC (Large Unstained Cell) values play a predictive role in preventing unnecessary biopsy due to prostatitis? Bugra Bilge Keseroglu
S-34 Hounsfield Units (HU): Promissing Non-Invasive Tool for Diagnosing Benign Prostatic Hyperplasia (BPH) Cumhur Yesildal
S-35 Granulomatous Prostatitis Due To Intravesical BCG Treatment Huseyin Cihan Demirel
S-36 A Rare Prostate Pathology: Mantle Cell Lymphoma Selman Unal
V-01 Preservation of Accesory Pudental Arteries in Robot-Assited Radical Prostatectomy Yusuf Arikan
23:00-23:10 Closing remarks Dr. Erdem Canda
18th International Prostate Forum